MASSIMO CRISTOFANILLI was appointed associate director for precision medicine and translational research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and director of Northwestern OncoSET.
Cristofanilli will serve as a professor of medicine in the Division of Hematology-Oncology at Northwestern University Feinberg School of Medicine. His work has focused on the translational research and treatment of patients with inflammatory breast cancer.
Cristofanilli comes to Northwestern from Thomas Jefferson University, where he served as director of Jefferson Breast Care Center and deputy director of Translational Research at the Kimmel Cancer Center.
Previously, Cristofanilli was chair of the Department of Medical Oncology at Fox Chase Cancer Center, and executive director of the Morgan Welch Inflammatory Breast Cancer Program and Clinic at MD Anderson Cancer Center.
As associate director for precision medicine and director of Northwestern OncoSET, Cristofanilli will oversee the development of OncoSET and related clinical and research operations. The program involves sequencing tumor genetic profiles and evaluating the results to provide the treatments or clinical trials that will offer the greatest benefit.
